Overview
As the incidence of endometrial cancer continues to rise, concerns have been raised regarding the potential exacerbation of existing inequities by the COVID-19 pandemic due to delays in care.
This study reviews endometrial cancer survival rates in recent years, focusing on racial and ethnic inequities. Additionally, the research explores the influence of social determinants of health on these survival inequities.
Why this matters
This study unveils enduring inequities in endometrial cancer survival, particularly among Black patients, both before and after the COVID-19 pandemic. Black patients consistently faced later-stage and aggressive disease, with significantly shorter survival compared to their White counterparts. Notably, clinical and social determinants of health accounted for a substantial portion of this survival gap. These findings emphasize the critical need for targeted interventions addressing systemic inequities to improve endometrial cancer outcomes and promote health equity.
View the abstract on the ISPOR website
More from Flatiron Health at ISPOR US 2024
Read about Flatiron's accepted research and presence at ISPOR US.
